SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹4.98 Cr | ₹4.42 Cr | ₹4.58 Cr | ₹7.16 Cr | ₹5.85 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹4.98 Cr |
Mar2023 | ₹4.42 Cr |
Mar2022 | ₹4.58 Cr |
Mar2017 | ₹7.16 Cr |
Mar2016 | ₹5.85 Cr |
How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.98 Cr | 12.55 | |
Mar2023 | ₹4.42 Cr | -3.34 | |
Mar2022 | ₹4.58 Cr | -36.07 | |
Mar2017 | ₹7.16 Cr | 22.41 | |
Mar2016 | ₹5.85 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,613.0 Cr | 2.3% | -5.6% | -14.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 2.3% |
-5.6% |
-14.3% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses